Pharmafile Logo
Pharmafocus logo
Advanced Search

Rovi wins Spanish contract for flu vaccines

pharmafile | July 1, 2009 | News story | Manufacturing and Production, Research and Development |  Europe, Rovi, Spain 

Related Content

EC approves combination treatment for kidney cancer

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line …

spravato

Janssen’s esketamine nasal spray gets Europe approval for new indication

The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered …

xellia

Xellia Pharmaceuticals becomes member of Medicines for Europe

Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, has become a member of Medicines for …

The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025